Cannibics Pharmaceuticals (QB) Stock Price - CNBX

-0.0215 (-5.24%)
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cannibics Pharmaceuticals Inc (QB) CNBX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0215 -5.24% 0.3885 0.382 0.42 0.395 0.41 16:21:02
Bid Price Ask Price Spread Spread % News
0.3601 0.435 0.0749 17.22% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
66 169,926 $ 0.390613 $ 66,375 668,454 0.066 - 0.61
Last Trade Time Type Quantity Stock Price Currency
15:59:18 500 $ 0.3885 USD

Cannibics Pharmaceuticals (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 52.40M 134.89M $ -3.78M - - 45.32M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
777.30k $ - 0.00% - -

more financials information »

Cannibics Pharmaceuticals (QB) News

Loading Messages....

Latest CNBX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CNBX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.370.4450.350.3995878217,5740.01855.0%
1 Month0.4070.610.290.4499964700,144-0.0185-4.55%
3 Months0.1250.610.0660.3299163691,7190.2635210.8%
6 Months0.2550.610.0660.3015879376,3410.133552.35%
1 Year0.399850.610.0660.3089587241,057-0.01135-2.84%
3 Years4.247.600.0661.48365,371-3.85-90.84%
5 Years0.24757.600.0211.37311,1110.14156.97%

Cannibics Pharmaceuticals (QB) Description

Cannabics Pharmaceuticals Inc. (CNBX), is dedicated to the development of personalized diagnostic tools to provide supportive data for practitioners and patients regarding cannabinoid based cancer therapy. The Company's R&D is based in Israel, where it is fully licensed by the Ministry of Health and involves both scientific and current medical clinical studies which are registered with the US NIH. Cannabics is now creating tailored therapies for cancer patients, utilizing advanced Liquid Biopsy and HTS technology along with personalized bioinformatics tools. Cannabics' research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on the confluence of cutting edge technologies and personalized bioinformatic markers.

Your Recent History
Cannibics ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.